Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil for refractory coronary vasospasm during cardiac catheterization
jRCT2091220366Completed
- Sponsor
- Hiroaki Shimokawa
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Coronary vasospasm (CAS) comparing Fasudil arm with Saline placebo arm (2 arms). Started Jul 2018; status: completed.
02
Drugs
fasudil
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on jRCT2091220366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220366.